1. Home
  2. PUBM vs TECX Comparison

PUBM vs TECX Comparison

Compare PUBM & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PubMatic Inc.

PUBM

PubMatic Inc.

HOLD

Current Price

$16.39

Market Cap

747.5M

Sector

Technology

ML Signal

HOLD

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$29.78

Market Cap

618.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PUBM
TECX
Founded
2006
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
747.5M
618.9M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
PUBM
TECX
Price
$16.39
$29.78
Analyst Decision
Buy
Strong Buy
Analyst Count
7
5
Target Price
$12.43
$75.20
AVG Volume (30 Days)
804.1K
209.7K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
40.70
EPS
N/A
N/A
Revenue
$282,926,000.00
N/A
Revenue This Year
$3.44
N/A
Revenue Next Year
$7.86
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.15
$14.39
52 Week High
$18.44
$39.53

Technical Indicators

Market Signals
Indicator
PUBM
TECX
Relative Strength Index (RSI) 56.30 39.19
Support Level $8.67 $27.30
Resistance Level $18.44 $31.39
Average True Range (ATR) 0.59 2.46
MACD -0.18 -0.67
Stochastic Oscillator 30.23 3.84

Price Performance

Historical Comparison
PUBM
TECX

About PUBM PubMatic Inc.

PubMatic Inc is is an independent, artificial intelligence-powered advertising technology company that delivers digital advertising performance. Its integrated technology platform connects buyers, publishers, data providers, and commerce media networks on a single, unified platform, to deliver advertising performance, control, transparency and efficiency. Its platform empowers the world's digital content creators (publishers) to maximize monetization of their advertising inventory and audiences and provides control and transparency to buyers, which includes advertisers, agencies, agency trading desks, and demand side platforms (DSPs) (referred as buyers). Geographically, the company generates the majority of its revenue from the United States, followed by EMEA, APAC, and Rest of the World.

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: